Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in the Treatment of School-Aged Children with Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry

Volumn 61, Issue 5, 2007, Pages 706-712

  Donner, Richard ^a   Michaels, M Alex ^b   Ambrosini, Paul J ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SHIRE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Adderall XR; ADHD; cardiovascular effects; children; mixed amphetamine salts extended release; stimulant

Indexed keywords

AMPHETAMINE;

ARTICLE; CARDIOVASCULAR PARAMETERS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT ANTERIOR BUNDLE BRANCH BLOCK; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPOTENSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE RATE; QT INTERVAL; QT PROLONGATION; SIDE EFFECT; SINUS TACHYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SYSTOLIC BLOOD PRESSURE; T WAVE; TACHYCARDIA;

ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHILD; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SINGLE-BLIND METHOD;

EID: 33847301894     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.05.002     Document Type: Article

References (19)

1. Adderall X.R. (mixed amphetamine salts extended release) prescribing information (2005), Shire US Inc, Wayne, PA
2. Ambrosini P.J., Sallee F.R., Lopez F.A., Shi L., Michaels M.A., and LADD CAT Study Group. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD. Curr Med Res Opin 22 (2006) 427-440
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (2000), American Psychiatric Press, Washington, DC text revision
4. Conners C.K. Conners' Rating Scales-Revised: Technical Manual (1997), Multi-Health Systems, North Tonawanda, NY
5. Findling R.L., Biederman J., Wilens T.E., Spencer T.J., McGough J.J., Lopez F.A., et al. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. J Pediatr 147 (2005) 348-354
6. Findling R.L., Short E.J., and Manos M.J. Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 40 (2001) 525-529
7. Greenhill L.L., Pliszka S., Dulcan M.K., Bernet W., Arnold V., Beitchman J., et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41 (2002) 26S-49S
8. Gutgesell H., Atkins D., Barst R., Buck M., Franklin W., Humes R., et al. AHA Scientific Statement: Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatry 38 (1999) 1047-1050
9. Guy W. Clinical Global Impressions (CGI). ECDEU Assessment Manual for Psychopharmacology (1976), U.S. Dept of Health and Human Services, Public Health Service, Alcohol Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Bran, Rockville, MD 218-222
10. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163 (2006) 716-723
11. McGough J.J., Biederman J., Greenhill L.L., McCracken J.T., Spencer T.J., Posner K., et al. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry 42 (2003) 684-691
12. Siberry G.K., and Iannone R. The Harriet Lane Handbook. 15th ed. (2000), CV Mosby, St. Louis
13. Swanson J.M., Wigal S.B., Wigal T., Sonuga-Barke E., Greenhill L.L., Biederman J., et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 113 3 pt 1 (2004) e206-e216. http://pediatrics.org/cgi/content/full/113/3/e206 Available at: http://pediatrics.org/cgi/content/full/113/3/e206. Accessed May 31, 2005.
14. Tulloch S.J., Zhang Y., McLean A., and Wolf K.N. SLI381 (Adderall XR), a two-component extended-release formulation of mixed amphetamine salts: Bioavailability of three test formulations and comparisons of fasted, fed, and sprinkled administration. Pharmacotherapy 22 (2002) 1405-1415
15. U.S. Food and Drug Administration. Public Health Advisory for Adderall and Adderall XR. Available at: http://www.fda.gov/cder/drug/advisory/adderall.htm. Accessed March 7, 2005.
16. Weisler R.H., Biederman J., Spencer T.J., and Wilens T.E. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 10 12 suppl 20 (2005) 35-43
17. Wilens T.E., Biederman J., Lerner M., and Concerta Study Group. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study. J Clin Psychopharmacol 24 (2004) 36-41
18. Wilens T.E., Hammerness P.G., Biederman J., Kwon A., Spencer T.J., Clark S., et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 66 (2005) 253-259
19. Wren C., O'Sullivan J.J., and Wright C. Sudden death in children and adolescents. Heart 83 (2000) 410-413